薬局自動化市場：製品別・薬局の種類別・薬局の規模別・用途別・エンドユーザー別・流通チャネル別・地域別（2026～2032年）

薬局自動化市場の評価（2026～2032年）

深刻な健康被害につながる可能性のある投薬ミスの発生率が上昇していることが、薬局自動化の重要な促進要因となっています。薬局自動化市場規模は2024年に56億2,000万米ドルと推定され、2032年には95億9,000万米ドルに達すると予測されます。

世界人口の高齢化と慢性疾患の増加が処方薬需要の急増につながり、薬局のような医療施設に在庫管理、調剤、タイムリーな患者配送の確保という課題を投げかけているため、市場は2026年から2032年までCAGR 7.62%で成長します。

薬局自動化市場の定義/概要

薬局自動化とは、薬局内での医薬品の取り扱い、保管、調剤、管理に関わる様々なプロセスを合理化・自動化する技術の使用を指します。これには、薬剤師や技術者が手作業で行っていた反復作業を実行するように設計された機械、ロボット、ソフトウェアシステムの組み合わせが含まれます。

薬局自動化の主な目的は、業務効率を高め、正確性を向上させ、投薬ミスを減らし、最終的にはより良い患者ケアを提供することです。錠剤の計数、在庫管理、処方箋へのラベル貼りなどの作業を自動化することで、薬局はヒューマンエラーのリスクを大幅に減らすことができ、また、スタッフをより複雑で患者中心の活動に集中させることができます。1960年代後半にシンプルな錠剤計数機で始まって以来、薬局自動化は人工知能や機械学習などの高度な技術を統合した洗練されたシステムへと進化し、今日の薬局の運営方法を一変させています。

投薬ミスを最小限に抑えるニーズの高まりは、薬局自動化市場の推進にどのような役割を果たすのか？

投薬ミスを最小限に抑える必要性の高まりは、患者の安全に重大なリスクをもたらすため、薬局自動化市場を大きく牽引しています。米国食品医薬品局（FDA）によると、投薬ミスは米国だけで年間約150万人に危害を及ぼしています。また、世界保健機関（WHO）は、このような過誤が、世界全体で毎年12万5,000人の予防可能な死亡につながっていると推定しています。このような憂慮すべき統計は、調剤と管理の精度を高め、ヒューマンエラーの可能性を減らす自動化システムの緊急の必要性を強調しています。

自動調剤キャビネットやロボットシステムなどの薬局自動化技術は、様々な薬局業務を合理化し、手作業に伴うミスのリスクを大幅に低減します。Institute for Safe Medication Practicesの調査によると、投薬ミスの約40%は詰め替え作業中に発生しており、有害事象につながるまで気づかれないことが多いです。自動化ソリューションを導入することで、薬局は複雑な投薬レジメンを管理する医療専門家の負担を軽減しながら、患者の安全性と業務効率を向上させることができます。医療提供者が医療の質を高め、関連するリスクを最小限に抑えようとする中、このようなエラー削減への注目が薬局自動化の成長を促進しています。

初期投資コストの高さは、薬局自動化技術の普及にどのような影響を与えるか？

初期投資コストの高さは、薬局自動化技術の導入に大きな影響を与え、多くの医療提供者にとって大きな障壁となっています。これらのシステムを導入するには、多くの場合、機器、インフラの修正、既存のワークフローとの統合に多額の資金を必要とします。あるレポートによると、プライマリ・ケアのセットアップの約80%は、自動化システム導入の主な障害として、財政的支援の欠如を挙げています。

さらに、米国食品医薬品局（FDA）は、投薬ミスが医療費の増加につながることを強調し、費用対効果の高いソリューションの必要性を強調しています。その結果、自動化の長期的なメリットは大きいかもしれないが、初期費用が多くの薬局の移行を阻み、市場全体の成長を遅らせています。

目次

第1章 イントロダクション

• 市場の定義
• 市場区分
• 分析手法

第2章 エグゼクティブサマリー

• 主な分析結果
• 市場概要
• 市場ハイライト

第3章 市場概要

• 市場規模と成長可能性
• 市場動向
• 市場促進要因
• 市場抑制要因
• 市場機会
• ポーターのファイブフォース分析

第4章 薬局自動化市場：製品別

• システム
• ソフトウェア
• サービス

第5章 薬局自動化市場：薬局の種類別

• 独立型
• チェーン店
• 連邦政府

第6章 薬局自動化市場：薬局の規模別

• 大規模薬局
• 中規模薬局
• 小規模薬局

第7章 薬局自動化市場：用途別

• 調剤・包装
• 医薬品保管
• 在庫管理

第8章 薬局自動化市場：エンドユーザー別

• 入院患者薬局
• 外来患者薬局
• 小売薬局
• オンライン薬局
• セントラルフィル/通販薬局
• 薬局給付管理機関

第9章 薬局自動化市場：流通チャネル別

• 直接入札
• 第三者販売業者

第10章 地域別分析

• 北米
• 米国
• カナダ
• メキシコ
• 欧州
• 英国
• ドイツ
• フランス
• イタリア
• アジア太平洋
• 中国
• 日本
• インド
• オーストラリア
• ラテンアメリカ
• ブラジル
• アルゼンチン
• チリ
• 中東・アフリカ
• 南アフリカ
• サウジアラビア
• アラブ首長国連邦

第11章 市場力学

• 市場促進要因
• 市場抑制要因
• 市場機会
• 新型コロナウイルス感染症 (COVID-19) の市場への影響

第12章 競合情勢

• 主要企業
• 市場シェア分析

第13章 企業プロファイル

• McKesson Corporation
• Omnicell, Inc.
• Cerner Corporation
• Swisslog Holding AG
• BD（Becton, Dickinson and Company）
• Capsa Healthcare
• Parata Systems LLC
• ScriptPro LLC
• ARxIUM Inc.
• TCGRx
• Talyst
• Baxter International
• Health Robotics SRL
• Yuyama , Ltd.
• Pearson Medical Technologies
• Kirby Lester
• Willach Pharmacy Solutions
• Innovation Associates
• KUKA AG

第14章 市場の展望と機会

• 新興技術
• 今後の市場動向
• 投資機会

第15章 付録

• 略語リスト
• 出典と参考文献

Pharmacy Automation Market Valuation - 2026-2032

The rising incidence of medication errors, which can lead to severe health consequences, is a significant driver for pharmacy automation. The pharmacy automation market size is estimated at USD 5.62 Billion in 2024, and is expected to reach USD 9.59 Billion by 2032.

The aging global population and rising chronic diseases have led to a surge in prescription medication demand, posing challenges for healthcare facilities like pharmacies in managing inventory, dispensing medications, and ensuring timely patient delivery enabling the market grow at a CAGR of 7.62% from 2026 to 2032.

Pharmacy Automation Market: Definition/ Overview

Pharmacy automation refers to the use of technology to streamline and automate various processes involved in the handling, storage, dispensing, and management of medications within a pharmacy. This includes a combination of machines, robotics, and software systems designed to perform repetitive tasks that would otherwise be done manually by pharmacists and technicians.

The primary goal of pharmacy automation is to enhance operational efficiency, improve accuracy, reduce medication errors, and ultimately provide better patient care. By automating tasks such as counting pills, managing inventory, and labeling prescriptions, pharmacies can significantly decrease the risk of human error while also freeing up staff to focus on more complex and patient-centered activities. Since its inception in the late 1960s with simple pill- counting machines, pharmacy automation has evolved into sophisticated systems that integrate advanced technologies like artificial intelligence and machine learning, transforming how pharmacies operate today.

What Role does the Increasing Need to Minimize Medication Errors Play in Driving the Pharmacy Automation Market?

The increasing need to minimize medication errors significantly drives the pharmacy automation market, as these errors pose serious risks to patient safety. According to the U.S. Food and Drug Administration (FDA), medication errors harm approximately 1.5 million people annually in the United States alone. Additionally, the World Health Organization (WHO) estimates that these errors lead to 125,000 preventable deaths each year globally. Such alarming statistics underscore the urgent need for automated systems that enhance accuracy in medication dispensing and management, thereby reducing the likelihood of human error.

Pharmacy automation technologies, such as automated dispensing cabinets and robotic systems, streamline various pharmacy operations, significantly decreasing the risk of mistakes associated with manual processes. A study by the Institute for Safe Medication Practices found that about 40% of medication errors occur during the refill process, often going unnoticed until they result in adverse events. By implementing automation solutions, pharmacies can improve patient safety and operational efficiency while alleviating the burden on healthcare professionals managing complex medication regimens. This focus on error reduction is propelling the growth of pharmacy automation as healthcare providers seek to enhance care quality and minimize associated risks.

How do High Initial Investment Costs Impact the Adoption of Pharmacy Automation Technologies?

High initial investment costs significantly impact the adoption of pharmacy automation technologies, posing a considerable barrier for many healthcare providers. Implementing these systems often requires substantial financial outlay for equipment, infrastructure modifications, and integration with existing workflows. According to a report, around 80% of primary care setups cite a lack of financial support as a major hindrance to adopting automation systems.

Additionally, the U.S. Food and Drug Administration (FDA) has highlighted that medication errors lead to increased healthcare costs, emphasizing the need for cost-effective solutions. Consequently, while the long-term benefits of automation may be substantial, the upfront costs deter many pharmacies from making the transition, slowing overall market growth.

Category-Wise Acumens

How do Inpatient Pharmacy Automation Systems Enhance the Tracking and Management of Controlled Substances?

Inpatient pharmacy automation systems enhance the tracking and management of controlled substances by providing real-time visibility and accountability throughout the medication-use process. For instance, a study at Houston Methodist Hospital demonstrated that implementing mobile medication tracking technology improved documentation accuracy significantly, with missing documents dropping from 29 to zero after transitioning from a paper-based system.

This technology ensured that 140 out of 141 medications had receiving personnel information documented electronically, improving the capture rate of medication delivery personnel from 67.4% to 92.9%. Such advancements minimize the risk of diversion and enhance compliance with regulations set by the U.S. Drug Enforcement Administration (DEA).

Additionally, automated systems streamline the ordering, storing, and dispensing processes for controlled substances, which helps reduce human error and improve overall efficiency. The FDA emphasizes the importance of meticulous record-keeping for controlled substances to prevent misuse, and automated systems facilitate this by providing accurate tracking and reporting capabilities. By integrating these technologies into hospital workflows, pharmacies can ensure a reliable chain of custody for controlled substances, thereby enhancing patient safety and supporting healthcare providers in maintaining compliance with regulatory requirements.

What Role does Regulatory Compliance Play in Motivating Large Size Pharmacies to Adopt Pharmacy Automation Technologies?

Regulatory compliance plays a crucial role in motivating large size pharmacies to adopt pharmacy automation technologies. With stringent regulations set by agencies such as the U.S. Food and Drug Administration (FDA) and the Centers for Medicare and Medicaid Services (CMS), large pharmacies must ensure they meet various safety and quality standards. For instance, the FDA emphasizes the importance of accurate record-keeping and reporting, which can be labor-intensive and prone to human error when done manually. Automation systems streamline data collection and reporting processes, significantly reducing the risk of compliance issues.

Moreover, automated systems can monitor access to protected health information (PHI) and alert staff to potential compliance violations, thereby enhancing accountability. The Health Insurance Portability and Accountability Act (HIPAA) mandates strict data privacy measures, and automation aids in maintaining these standards by ensuring secure handling of sensitive information. By leveraging automation technologies, large pharmacies can improve their compliance efforts, reduce the likelihood of costly penalties, and enhance overall operational efficiency, making them more agile in responding to regulatory changes.

Country/Region-wise Acumens

What Factors Contribute to the Rapid Growth of Pharmacy Automation Technologies in the Asia Pacific Region?

The rapid growth of pharmacy automation technologies in the Asia Pacific region is driven by several key factors. A significant contributor is the aging population, with projections indicating that by 2025, Asia will have 456 million seniors aged 65 or older, representing 10% of its population. This demographic shift increases the demand for efficient medication management systems.

Additionally, government initiatives aimed at improving healthcare access and quality are crucial; for instance, the Asian Development Bank (ADB) has committed over USD 20 Billion in assistance to enhance healthcare systems in response to challenges posed by the COVID-19 pandemic. These factors, combined with rising consumer expectations and technological advancements, create a conducive environment for the swift adoption of pharmacy automation technologies across the region.

What Technological Innovations are Driving the Adoption of Pharmacy Automation Systems in North America?

Technological innovations are pivotal in driving the adoption of pharmacy automation systems in North America. Key advancements include robotic dispensing systems, which enhance accuracy by automating the counting, labeling, and dispensing of medications. For instance, the U.S. Food and Drug Administration (FDA) reports that medication errors contribute to approximately 100,000 adverse events annually, highlighting the urgent need for solutions that minimize such risks.

Additionally, artificial intelligence (AI) and machine learning are being integrated into inventory management systems to optimize stock levels and reduce waste. The Centers for Medicare & Medicaid Services (CMS) also supports the use of automation to improve patient safety and operational efficiency. As healthcare providers increasingly focus on minimizing medication errors and enhancing workflow, these technological innovations are essential in transforming pharmacy operations, ultimately leading to better patient outcomes and satisfaction.

Competitive Landscape

The competitive landscape of the pharmacy automation market is characterized by intense competition among a diverse array of players, including established pharmaceutical companies, medical device manufacturers, and technology firms.

Some of the prominent players operating in the pharmacy automation market include:

• McKesson Corporation
• Omnicell,
• BD (Becton, Dickinson and Company)
• AmerisourceBergen Corporation
• Swisslog Healthcare
• Capsa Healthcare
• Talyst,
• Cerner Corporation
• Baxter International
• ScriptPro LLC
• ARxIUM,
• Health Robotics SRL
• Yuyama , Ltd.
• ScriptPro LLC
• TCGRx
• Pearson Medical Technologies
• Kirby Lester
• Willach Pharmacy Solutions
• Innovation Associates
• KUKA AG

Latest Developments

• In April 2024, Omnicell Launch XR2 Automated Central Pharmacy System, which offers a fully automated approach to medication inventory management, enhancing patient safety through 100% barcode scanning and reducing expired medication
• In January 2024, AmerisourceBergen completed its acquisition of PharmaLex Holding GmbH, enhancing its specialty services and expanding its platform for pharmaceutical manufacturer services, which includes pharmacy automation

Pharmacy Automation Market, By Category

• Product:
• Systems
• Software
• Services
• Pharmacy Type:
• Independent
• Chain
• Federal
• Pharmacy Size:
• Large Size Pharmacy
• Medium Size Pharmacy
• Small Size Pharmacy
• Application:
• Drug Dispensing and Packaging
• Drug Storage
• Inventory Management
• End-User:
• Inpatient Pharmacies
• Outpatient Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Central Fill/Mail Order Pharmacies
• Pharmacy Benefit Management Organizations
• Distribution Channel:
• Direct Tender
• Third Party Distributor
• Region:
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

TABLE OF CONTENTS

1. INTRODUCTION

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. Pharmacy Automation Market, By Product

• Systems
• Software
• Services

5. Pharmacy Automation Market, By Pharmacy Type

• Independent
• Chain
• Federal

6. Pharmacy Automation Market, By Pharmacy Size

• Large Size Pharmacy
• Medium Size Pharmacy
• Small Size Pharmacy

7. Pharmacy Automation Market, By Application

• Drug Dispensing and Packaging
• Drug Storage
• Inventory Management

8. Pharmacy Automation Market, By End-User

• Inpatient Pharmacies
• Outpatient Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Central Fill/Mail Order Pharmacies
• Pharmacy Benefit Management Organizations

9. Pharmacy Automation Market, By Distribution Channel

• Direct Tender
• Third Party Distributor

10. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

11. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

12. Competitive Landscape

• Key Players
• Market Share Analysis

13. Company Profiles

• McKesson Corporation
• Omnicell, Inc.
• Cerner Corporation
• Swisslog Holding AG
• BD (Becton, Dickinson and Company)
• Capsa Healthcare
• Parata Systems LLC
• ScriptPro LLC
• ARxIUM Inc.
• TCGRx
• Talyst
• Baxter International
• Health Robotics SRL
• Yuyama , Ltd.
• Pearson Medical Technologies
• Kirby Lester
• Willach Pharmacy Solutions
• Innovation Associates
• KUKA AG

14. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

15. Appendix

• List of Abbreviations
• Sources and References